SHANNON HUSSEY: Open Payments
NPI 1275509739 · LITTLE RIVER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,078 in 108 payments from 26 companies in 2025. Trend: 2023 $1,910 · 2024 $1,667 · 2025 $2,078
Food & beverage: $2,078
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $334 |
| AstraZeneca Pharmaceuticals LP | 9 | $310 |
| Amgen Inc. | 11 | $263 |
| ABBVIE INC. | 25 | $194 |
| GlaxoSmithKline, LLC. | 7 | $113 |
| PFIZER INC. | 6 | $111 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $106 |
| Novartis Pharmaceuticals Corporation | 5 | $81 |
| ACADIA Pharmaceuticals Inc | 3 | $78 |
| Daiichi Sankyo Inc. | 2 | $56 |
Products named: AIRSUPRA, Ozempic, Repatha, XIFAXAN, UBRELVY, Wegovy, LEQVIO, NUPLAZID.
Industry payments across SC — which companies pay providers there.
